SPY+1.76%QQQ+3.14%NVDA+3.54%MSFT+2.31%AAPL+1.82%GOOGL+2.69%META+4.67%AMZN+3.13%TSLA+1.16%AVGO+3.11%SPY+1.76%QQQ+3.14%NVDA+3.54%MSFT+2.31%AAPL+1.82%GOOGL+2.69%META+4.67%AMZN+3.13%TSLA+1.16%AVGO+3.11%

← back to Psychedelic Medicine Breakthrough Index

Holding

CybinCYBN

Deuterated psilocybin analogue CYB003 in Phase 2 for MDD; fast-acting formulation.

weight · 11.00%·sector · Healthcare·exchange · NYSE

Price

TradingView Advanced Chart

Snapshot

Quote + description

Technical analysis

Oscillators + moving averages

Fundamentals

Revenue / margins / balance sheet

Company profile

News

Ticker-scoped headlines

/home·/markets·/feed·/leaderboard·/sharpe·/blog·/pricing·/about·/vacancies·/contact·/links·/terms

⚠Investment research & data tool · not investment advice · not a regulated broker or advisor · past performance does not guarantee future results.